The transcriptional landscape and mutational profile of lung adenocarcinoma.
about
Gene aberrations for precision medicine against lung adenocarcinomaBiomarker development in MET-targeted therapyRegulatory Crosstalk by Protein Kinases on CFTR Trafficking and Activity.The influence of subclonal resistance mutations on targeted cancer therapyPatterns of Chromosomal Aberrations in Solid TumorsDifferences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese populationDysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistanceEfficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer: A Meta-Analysis and Systemic ReviewMutational signatures: the patterns of somatic mutations hidden in cancer genomesBeyond ALK-RET, ROS1 and other oncogene fusions in lung cancerThe minority report: targeting the rare oncogenes in NSCLCSWI/SNF chromatin remodeling complexes and cancerWill the Requirement by the US FDA to Simultaneously Co-Develop Companion Diagnostics (CDx) Delay the Approval of Receptor Tyrosine Kinase Inhibitors for RTK-Rearranged (ROS1-, RET-, AXL-, PDGFR-α-, NTRK1-) Non-Small Cell Lung Cancer Globally?Identification of targetable FGFR gene fusions in diverse cancers.Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.Oncogenic RIT1 mutations in lung adenocarcinoma.PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutationsResponse to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skippingTesting for ROS1 in non-small cell lung cancer: a review with recommendationsTargeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALKComprehensive molecular profiling of lung adenocarcinoma.An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101Inactivating CUX1 mutations promote tumorigenesisIdentification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokersPredilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patientsEmergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumoursSignatures of mutational processes in human cancerLMTK2-mediated phosphorylation regulates CFTR endocytosis in human airway epithelial cells.TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer.The mutational landscape of chromatin regulatory factors across 4,623 tumor samples.Gene set enrichment analysis of RNA-Seq data: integrating differential expression and splicingReliable identification of genomic variants from RNA-seq dataDiscovering and understanding oncogenic gene fusions through data intensive computational approachesIntegrated molecular portrait of non-small cell lung cancers.Clinicopathological and demographical characteristics of non-small cell lung cancer patients with ALK rearrangements: a systematic review and meta-analysis.Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer.Network topology-based detection of differential gene regulation and regulatory switches in cell metabolism and signalingMolecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis.Overexpression of LINC00152 correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer.
P2860
Q26749348-02E8E877-7512-4207-97F4-2F26AEC7C160Q26751332-2EC9C187-DFFB-4309-AA7A-7CD19AFD1E17Q26770258-495913D9-01DB-4754-A857-3E0F185F0C09Q26781693-484EF41D-5EDE-40F3-9C3E-AFB3F1697F9CQ26786127-393AC76D-614B-48CD-9434-3F744B5B4D7EQ26786594-ED8098E8-C555-4FC0-9BB3-B03A65DBB45FQ26799900-DD37F65B-F2EE-4D0B-8F76-A6E4CC86F466Q26801118-8C85E185-35AA-4905-89C3-C6AB1525B978Q26850125-DF42B5B3-0008-4A53-95BB-0A54AA8D4CA5Q26851421-5FEADA92-F41A-4C17-8488-33BEB85E5C9DQ26851636-D142747A-70A9-4021-B563-04D918152715Q26998657-84531EA7-6039-4DC3-B040-A4718D23EB2BQ27023383-70FE3042-33F4-4DE1-95F8-28FAF52A5EB5Q27852147-F07EF44E-5BFE-47D3-B6B6-16E808C00F98Q27852601-2FC0154A-2798-419A-9200-1BBC90A5F19FQ27852800-38C3F0FE-9A5C-45D4-9488-ED0595D1D4E2Q27853138-B32DA476-E7C1-4309-B4CC-9CF543C5BB19Q27853167-720E1FA4-5823-4868-85E0-19881E5788AEQ28070062-4146CF33-0983-48B2-8DF7-110831092D12Q28083446-AD84D605-237D-4921-B0DD-6F0306556DE1Q28244995-E276E562-7162-4264-B251-B57D9810BF35Q28265615-78F1B613-1292-4E90-8E0C-7E81FAA25795Q28303563-1C3A8252-015C-4D15-9BEC-3A6642BE563BQ28383535-69DE5B08-AD71-45C4-B6DA-658332F1AD3DQ28385873-40C00CD0-73F8-4E78-8850-0E23584D0778Q28609639-834BED59-9DC7-416C-8318-4C09EC7D3F71Q29547191-4D78CAD3-7172-4875-8C87-1BB23C2DCB4DQ30412916-2DAEE428-5007-4BD1-BDC3-4F8C43FB2B08Q30488162-E681210E-0DE3-4F7C-AA7A-1F6A93A2A78FQ30580509-A3B90495-F368-4717-9275-622869CB0C14Q30640271-D898D296-93CB-4B16-B6E0-56B4615E514BQ30670530-0C5D8838-B7C9-4BED-8FA8-E4C16EBC1A6EQ31083417-04E5B4CB-C56E-46A4-95F3-57FE6936C546Q31145455-4CBD85D1-5B5A-43B3-A0A5-78D39F1361E5Q31167585-ED8F3E3D-D1C9-4E5E-B193-0A5E73CB10AFQ33584831-329B90FB-F006-4D89-B235-D44D114E5F95Q33602552-B44F9C3F-F59B-4502-B56F-FE50A5CF20F3Q33650449-FA6897DF-2848-4A01-A998-0BCDBDD4F350Q33760940-8F4A6F32-C807-432E-8592-EE54D3B6A1AAQ33774226-E6747CD9-E4D8-405E-9FB3-11B925DA55FA
P2860
The transcriptional landscape and mutational profile of lung adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The transcriptional landscape and mutational profile of lung adenocarcinoma.
@ast
The transcriptional landscape and mutational profile of lung adenocarcinoma.
@en
type
label
The transcriptional landscape and mutational profile of lung adenocarcinoma.
@ast
The transcriptional landscape and mutational profile of lung adenocarcinoma.
@en
prefLabel
The transcriptional landscape and mutational profile of lung adenocarcinoma.
@ast
The transcriptional landscape and mutational profile of lung adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
The transcriptional landscape and mutational profile of lung adenocarcinoma
@en
P2093
Chang-Hyun Kang
Eung-Ryoung Lee
Hwanseok Rhee
In-Kyu Park
Jeong-Sun Seo
Jin-Hyoung Kang
Jong-Il Kim
Jong-Yeon Shin
June Koo Lee
P2860
P304
P356
10.1101/GR.145144.112
P577
2012-09-13T00:00:00Z